The North American and European markets are the main markets for advanced wound dressings, which are mainly based on advanced medical technologies and medical security mechanisms in developed countries.

The increase in chronic diseases is driving spending on chronic wounds. Functional wound dressings are mainly used to treat chronic and non-healing wounds. The current chronic wound treatment market is G8 countries. According to Delveinsight, the chronic wound market size was valued at USD 6.777 billion in 2017.

Forecast Year	Global Wound Care Market Size (Forecast)	Global Advanced Wound Care Market Size (Forecast)
2020	About $15.25 billion	About $8.97 billion
2021	About $17.49 billion	About $10.44 billion
2022	About $18.51 billion	About $10.92 billion
2026	About $27.8 billion	About $11.42 billion
2029	About $28.23 billion	About $11.94 billion

2021	Market Size
Global Wound Care	About $17.49 billion
Global Advanced Wound Care	About $10.44 billion
Global Chronic Wound Care	About $11.61 billion
North American Wound Care	About $6.69 billion
North American Chronic Wound Care	About $4.4 billion

The Wound Healing Association classifies chronic wounds into four categories based on etiology: pressure ulcers, diabetic ulcers, venous ulcers, arterial insufficiency ulcers.

The increase in the number of chronic wounds such as diabetic foot ulcers will contribute to the growth of the wound care market, which takes an average of 200 days to heal. According to relevant statistics, it is estimated that 115,000 people in the UK may suffer from diabetic foot ulcers; the annual cost of treating diabetic foot ulcers in Canada is about 547 million US dollars; the number of diabetic patients aged 20 to 79 in the world exceeds 460 million; about 2.5% The U.S. population suffers from chronic wounds such as diabetic foot ulcers; the cost of treating diabetic foot ulcers in Latin America is approximately $10,450 per patient.

《Estimated Global Prevalence Of People With Diabetes》

Region	Diabetes Prevalence
	1980	2014
Africa	3.1%	7.1%
Americas	5%	8.3%
Europe	5.3%	7.3%
Southeast asia	4.1%	8.6%

An increased number of varicose veins can lead to the development of venous leg ulcers, and according to statistical estimates, about 1 in 4 people in the U.S. population have varicose veins. Globally 278,000 people are treated for venous leg ulcers every year; approximately US$4.94 billion is spent on the treatment of venous leg ulcers and other related conditions in the United States; the annual cost of venous leg ulcer treatment in the UK is estimated at US$2.57 billion.

In addition, statistics show that an estimated 2.5 million acute care patients suffer from pressure injuries in the United States each year, and about 420,000 people in Australia are diagnosed with various types of wounds each year. The Australian government spends about $3 billion annually on chronic wounds treat.